
Closed
Source verified June 5, 2026
MEDTEQ+ — AVISÉ program
Support for evaluating innovative health technologies
Funding available
$ 500,000 - $ 700,000
Deadline
April 17, 2026
Opened March 13, 2026
Location
Quebec, Canada
Overview
The AVISÉ program provides non-repayable financial support of up to $700,000 to innovative Quebec-based life sciences companies for a real-world evaluation study close to commercialization. It supports projects that demonstrate the value of medical and digital health technologies through collaboration with RÉIS expert evaluation teams.
/100
Opportunity Score
Moderate potential, but conditions must align.
At a glance
Funding available
Financing goals
- Increase performance through digital transformation
- Develop strategic partnerships
- Increase production or service capacity
Eligible Funding
- Maximum amount : 700,000 $
- Minimum amount : 500,000 $
- Up to 50% of project cost
Eligible candidates
Eligible Industries
- All industries
Location
- Quebec
Legal structures
- For-profit business
- Social economy enterprise
Annual revenue
- All revenue ranges
Organisation size
- All organization sizes
Audience
- Canadians
- Startups
Next Steps
1
Determine your project
2
Validate your eligibility
Activities funded
- Evaluation of a new product, technology, or process in the health or medical sector that is near commercialization.
- Assessment of significant improvements to an existing product, technology, or process in healthcare, requiring research and development efforts.
- Projects that demonstrate the overall value and relevance of a health technology to facilitate market access in Quebec, nationally, or internationally.
- Studies conducted in collaboration with expert evaluation teams to test technologies addressing priority needs in areas such as primary care access, patient care pathways, task automation, or robotic surgery.
- Initiatives aiming to validate the commercial potential of a new health innovation, subject to technological or business risk, within an 18-month timeline.
Documents Needed
- Completed application form
- Letter of intent form
- Technology demonstration video
- Supporting scientific and technical documents
- Signed service offers from the evaluation team
Eligibility
Who is eligible?
- For-profit companies in the medical technology sector
- For-profit companies in digital health technologies, including those using artificial intelligence
- Social economy enterprises as defined by Quebec legislation
Who is not eligible
- Companies listed on the Register of Enterprises Ineligible for Public Contracts (RENA), including subcontractors registered on RENA.
- Companies listed on the non-compliance list for the francization process by the Office québécois de la langue française.
- Companies that have defaulted on obligations related to previous government financial assistance within the last two years.
- State-owned enterprises, companies controlled by government entities (municipal, provincial, or federal), municipal organizations, or companies majority-owned by a state enterprise.
- Holding companies, companies under bankruptcy or insolvency protection, and companies whose main activity relates to arms production, fossil fuel extraction/production (excluding carbon transition), gambling, violent games or combat sports, sexual exploitation, or tobacco/drug-related business.
Eligible expenses
- Direct labour costs dedicated to the project, including benefits and mandatory contributions.
- Student scholarships.
- Materials, consumables, and supplies required for the project.
- Purchase or rental of equipment (up to a maximum of 25% of total eligible expenses).
- Travel and accommodation expenses directly related to project execution, in accordance with government standards.
- Professional fees for technology evaluation by expert evaluators.
- Professional fees for the implementation and usage of the technology by evaluation sites.
- Professional and specialized service fees, and subcontracting expenses.
- Costs for disseminating project results.
- Fees for specialized platforms.
- Acquisition costs for studies or other documentation needed for the project.
- Monetary compensation for participant involvement.
- Project management fees charged by MEDTEQ+.
- Indirect research costs (FIR) related to the project.
Ineligible Costs and Activities
- Expenses incurred before the final submission deadline
- Regular operating expenses of the company
- Applicable Quebec sales taxes
- Recurring software subscription and update fees
- Capital expenditures, depreciation, and real estate or land acquisition work
Eligible geographic areas
- Quebec (companies must be registered in Quebec, have an establishment, and actively operate there)
Selection criteria
- Innovative character of the technology (maximum 25 points): Presence of a decisive advantage of the product or process compared to existing solutions nationally or internationally. Must obtain at least 80% (20 out of 25) for admissibility.
- Overall value of the innovation and social acceptability (maximum 25 points): Relevance for health systems, potential impact on various levels (population, clinical, organizational, sociocultural, environmental), response to identified priority needs, and social acceptance.
- Feasibility and relevance of the project in relation to the objectives of the call for projects (maximum 25 points): Quality and realism of the implementation plan, schedule and budget, quality of partners, risk management, sustainable development considerations, project pertinence, and risk assessment.
- Company's capacity to carry out the project (maximum 15 points): Alignment with business strategy, track record and key achievements, internal expertise and experience relevant to the project’s requirements.
- Potential benefits for the company and its sector (maximum 10 points): Market potential, business model and go-to-market strategy, commercialization experience, and intellectual property position and strategy.
How to apply
- Step 1: Contact MEDTEQ+ and confirm eligibility
- Request the application form from MEDTEQ+.
- Book a meeting with a MEDTEQ+ advisor to review eligibility.
- Step 2: Build the project with the evaluation team
- Present the technology and define the testing environment.
- Work with the expert evaluation team to structure the project.
- Step 3: Prepare the application package
- Complete the application form.
- Prepare the technology demonstration video and supporting documents.
- Obtain the signed service offer from the evaluation team.
- Step 4: Submit by email
- Send the complete file to projet@medteq.ca.
- Use the subject line requested by MEDTEQ+.
Processing and Agreement
- Applications are reviewed for eligibility and then assessed by an expert committee.
- Applicants may be invited to answer questions during a short interview if their file is complete and eligible.
- Successful applicants receive a funding decision and must sign a funding agreement before project launch.
- The approved project must begin once all required authorizations are in place.
- The company must submit follow-up and final reporting after the project.
Additional information
- Applicants must ensure the inclusion of all required documents, such as signed forms and video presentations, for a complete application.
- An online information session will be offered, with the recording subsequently available on the MEDTEQ+ website.
- Evaluation committees may request a brief Q&A session with applicants whose proposals are considered eligible.
- Annual follow-up reports on project outcomes are required one and two years after project completion.
Contacts
Frequently Asked Questions about the MEDTEQ+ — AVISÉ program Program
What is the MEDTEQ+ — AVISÉ program?
The AVISÉ program provides non-repayable financial support of up to $700,000 to innovative Quebec-based life sciences companies for a real-world evaluation study close to commercialization. It supports projects that demonstrate the value of medical and digital health technologies through collaboration with RÉIS expert evaluation teams.
How much funding can be received?
MEDTEQ+ — AVISÉ program Funds up to 50% of admissible expenses, capped at $700,000 per project.
What is the deadline to apply?
The application deadline for this grant program was April 17, 2026.
Who is eligible for the MEDTEQ+ — AVISÉ program program?
To be eligible for the MEDTEQ+ — AVISÉ program program, you must:
Legally constituted for-profit company in Quebec or Canada, registered and established in Quebec
Active in medical technology or digital health sectors (including AI)
Owns intellectual property rights for the product or innovation
What expenses are eligible under MEDTEQ+ — AVISÉ program?
Evaluation of a new product, technology, or process in the health or medical sector that is near commercialization.
Assessment of significant improvements to an existing product, technology, or process in healthcare, requiring research and development efforts.
Projects that demonstrate the overall value and relevance of a health technology to facilitate market access in Quebec, nationally, or internationally.
Studies conducted in collaboration with expert evaluation teams to test technologies addressing priority needs in areas such as primary care access, patient care pathways, task automation, or robotic surgery.
Initiatives aiming to validate the commercial potential of a new health innovation, subject to technological or business risk, within an 18-month timeline.
Who can I contact for more information about the MEDTEQ+ — AVISÉ program?
You can contact Consortium de recherche et d’innovation en technologies médicales du Québec (MEDTEQ) by email at avise@medteq.ca.
Where is the MEDTEQ+ — AVISÉ program available?
The MEDTEQ+ — AVISÉ program program is available the province of Quebec.